12:00 AM
 | 
Nov 15, 1999
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Collateral preclinical data

CLTX reported that it constructed an adenovirus expressing both proteins for use as a gene therapy. The company said...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >